New instrumentation, reagents, and methods, as well as increasing interest in small and single-cell samples, could prove a boon for the technology.
The method combines stable isotope dimethyl labeling with DiLeu isobaric tagging and allows multiplexing of up to 24 samples in a single mass spec experiment.
The multiplexed proteomic approach could offer better sensitivity and accuracy than existing methods while working with a wider range of instrumentation.
The approach uses isobaric tagging to quantify proteins in single cells, and is one of the first to bring mass spec analysis to the single-cell level.
The company plans to use the money to speed its transition to a contract research business model, and to support its TMT reagents business.
The company hopes that looking at multiple species of the phosphorylated tau protein could allow for earlier and more accurate diagnosis of the disease.
The company, which has struggled to turn its broad proteomics expertise into steady profits, plans to focus more tightly on its pharma services business.
The firm is placing about 13.9 million new shares of its stock at 18 pence per share.
The UK-based proteomics and lipidomics firm will offer solutions to help healthcare professionals utilizing protein expression data in patient care.
Proteome Sciences this week lowered its full year 2014 guidance, citing delays in the timing of several contracts.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.